This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emmanuel Cyrille Pascal Briend: Innovator in Antibody Development
Introduction
Emmanuel Cyrille Pascal Briend is a notable inventor recognized for his contributions to the field of biotechnology. He has made significant strides in the development of innovative therapies, particularly in the area of antibody engineering.
Latest Patents
Briend holds a patent for a polynucleotide encoding anti-TIGIT and anti-CD96 antibodies. This invention represents a crucial advancement in the development of therapeutic antibodies that can potentially enhance immune responses against cancer.
Career Highlights
Emmanuel Briend is currently associated with Ligand Pharmaceuticals, Inc., a company known for its focus on innovative drug development. His work at Ligand Pharmaceuticals has positioned him as a key player in the biotechnology sector.
Collaborations
Briend has collaborated with talented colleagues, including Beth Wensley and Spencer Campbell. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Emmanuel Cyrille Pascal Briend is a distinguished inventor whose work in antibody development continues to impact the field of biotechnology. His contributions, particularly through his patent, highlight the importance of innovation in advancing medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile